HOME ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE STORY OF OUR FIRM SEARCH

Mesothelioma Publication - Polish cases

This is an abstract of an article about Mesothelioma published at PubMed by the NIH.

Pol Merkuriusz Lek. 2004 Nov;17(101):479-82.

[Pleural mesothelioma--case with effusion in both pleural cavities]

Fijalkowski M, Jochymski C.

Wojewodzki Specjalistyczny Zespol Opieki Zdrowotnej, Centrum Leczenia Chorob Pluc w Lodzi, Oddzial Chorob Pluc i Alergii Ukladu Oddechowego.

Etiology of the pleural exudate is not always easy to establish with the routine diagnostic procedures. We report the history of a 55-year-old man, driver--without evident occupational exposure to asbestos dust. Patient was treated in hospital because of recurrent bilateral sanguineous pleural fluid. Repeated basic laboratory examinations of pleural exudate did not contribute to establishing etiology of the disease. At the beginning of hospital stay antituberculosis therapy was applied but was unsuccessful. Rapid accumulation of the fluid, deterioration of general condition of the patient, presence of dysplasia in the cells of the sediment of the exudate indicated possibility of diagnosis of neoplasm of the pleura. Intravenous injections of cisplatin and intrapleural application of bleomycin did not influence, however, the course of the disease. Final diagnosis was possible only after pleural biopsy (with Abrams needle) was performed. Histopathologic examination of the specimen disclosed: malignant mesothelioma biphasic type. Patient died after 3 months of observations and attempt at treatment.


PMID: 15754636 [PubMed - in process]

For additional information about our mesothelioma lawyers and a complimentary consultation, speak to a Client Relations representative at Weitz & Luxenberg today! Please fill out this simple form, call toll free 1 (800) 476-6070 or e-mail us at Clientrelations@weitzlux.com.

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

TABLE OF CONTENTS
Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Farnesyltransferase Inhibitors
Cancer Immunotherapy
Great Britain
Poland
Pemetrexed Therapy
Sv40 Specific Recall Immunity
Polish Cases
Extra Pleural Pneumonectomy
Intraoperative Radiation Therapy
Calretinin
Hyaluronan
Granulocyte Colony Stimulating Factor
Canada
Pemetrexed (Alimta)
Calretinin Antibodies
Greece
Neoplasia
FDA Pemetrexed
Secreted Frizzled Related Protein
Tumor Necrosis
Podoplanin
Lymphohistiocytoid
Pathogenesis of Malignant Pleural
Diagnostic Difficulties
Mesothelioma from Adenocarcinoma
Mesothelial Proliferation
ThinPrep Cytospin
Effusion
Chemotherapy Options
Heparanase
Malignant Deciduoid
Mortality
Pemetrexed in Malignant Pleural Mesothelioma
Pleural Mesothelioma
Prognostic Analysis
Italian Mortality Rates
Vinorelbine and Oxaliplatin
DNA Methylation Profiles
Primary Malignant Pericardial Mesothelioma
Abdominal CAT Scans
China
Disseminated Malignant
Statistical Validation
Pathogenesis
Lung Adenocarcinoma
Japan


RETURN BACK TO
Mesothelioma
Latest News
see also:

Pathogenesis Mesothelioma Publication - Read about pathogenesis
An article discussing mesothelioma pathogenesis

Granulocyte Colony Stimulating Factor Mesothelioma Publication: Granulocyte Colony Stimulating Factor
Mesothelioma article on Granulocyte Colony Stimulating Factor

Mesothelioma National Institute Health Publication The National Institute of Health Mesothelioma Research Publications
Mesothelioma Publications from the National Institute of Health